Journal of Adolescent Health
Volume 45, Issue 3 , Pages 303-309 , September 2009

Expedited Partner Therapy for Adolescents Diagnosed with Chlamydia or Gonorrhea: A Position Paper of the Society for Adolescent Medicine

References 

  1. Centers for Disease Control and Prevention. Legal Status of Expedited Partner Therapy (EPT). Atlanta, Georgia: US Department of Health and Human Services, 2007 [Online]. Available at http://www.cdc.gov/std/ept/legal. Accessed December 3, 2008.
  2. Centers for Law and the Public's Health. Legal Assessment Concerning Expedited Partner Therapies (EPT). Available at: http://www.publichealthlaw.net/Projects/EPT.php. Accessed December 19, 2008.
  3. American Medical Association. Report of the Council on Ethical and Judicial Affairs: CEJA Report 6-A-08. Available at: http://www.ama-assn.org/ama1/pub/upload/mm/471/ceja6.doc. Accessed December 19, 2008.
  4. Centers for Disease Control and Prevention. EPT Resources from States [Online]. Available at: http://www.cdc.gov/std/ept. Accessed December 3, 2008.
  5. American Medical Association. Report 7 of the Council on Science and Public Health (A-06): Expedited Partner Therapy (Patient-delivered Partner Therapy): An update. 2006. Available at: http://www.ama-assn.org/ama/pub/category/16410.html. Accessed December 3, 2008.
  6. Centers for Disease Control and Prevention. Expedited Partner Therapy in the Management of Sexually Transmitted Diseases. Atlanta, Georgia: US Department of Health and Human Services, 2006 [Online]. Available at http://www.cdc.gov/std/treatment/EPTFinalReport2006.pdf. Accessed December 3, 2008.
  7. Centers for Disease Control and Prevention. Legal Status of EPT—New Mexico. Atlanta, Georgia: US Department of Health and Human Services, 2007 [Online]. Available at http://www.cdc.gov/std/ept/legal/newmexico.htm. Accessed December 3, 2008.
  8. Centers for Disease Control and Prevention. Legal Status of EPT—Tennessee. Atlanta, Georgia: US Department of Health and Human Services, 2007 [Online]. Available at http://www.cdc.gov/std/ept/legal/tennessee.htm. Accessed December 3, 2008.
  9. Golden MR, Hughes JP, Brewer DD, et al. Evaluation of a population-based program of expedited partner therapy for gonorrhea and chlamydial infection. Sex Transm Dis. 2007;34:598–603
  10. Golden MR, Whittington WLH, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med. 2005;352:676–685
  11. Golden MR, Whittington WL, Handsfield HH, et al. Partner management for gonococcal and chlamydial infection: Expansion of public health services to the private sector and expedited sex partner treatment through a partnership with commercial pharmacies. Sex Transm Dis. 2001;28:658–665
  12. California Department of Health Services STD Control Branch. Patient-delivered Therapy of Antibiotics for Chlamydia trachomatis. California, 2001 [Online]. Available at: http://www.dhs.ca.gov/ps/dcdc/STD/docs/PDT_GUIDELINES_19.pdf. Accessed December 3, 2008.
  13. Datta SD, Sternberg M, Johnson R, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med. 2007;147:89–96
  14. Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. J Am Med Assoc. 2004;291:2229–2236
  15. Whittington WL, Kent C, Kissinger P, et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: Results of a multicenter cohort study. Sex Transm Dis. 2001;28:117–123
  16. Burstein GR, Snyder MH, Conley D, et al. Adolescent chlamydia testing practices and diagnosed infections in a large managed care organization. Sex Transm Dis. 2001;28:477–483
  17. Orr DP, Langefeld CD, Katz BP, et al. Behavioral intervention to increase condom use among high-risk female adolescents. J Pediatr. 1996;128:288–295
  18. Burstein GR, Zenilman JM, Gaydos CA, et al. Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females. Sex Transm Infect. 2001;77:26–32
  19. Fortenberry JD, Brizendine EJ, Katz BP, et al. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex Transm Dis. 1999;26:26–32
  20. St Lawrence JS, Montano DE, Kasprzyk D, et al. STD screening, testing, case reporting, and clinical and partner notification practices: A national survey of US physicians. Am J Public Health. 2002;92:1784–1788
  21. Fortenberry JD, Brizendine EJ, Katz BP, et al. The role of self-efficacy and relationship quality in partner notification by adolescents with sexually transmitted infections. Arch Pediatr Adolesc Med. 2002;156:1133–1137
  22. Mathews C, Coetzee N, Zwarenstein M, et al. Strategies for partner notification for sexually transmitted diseases. Cochrane Database Syst Rev. 2001;4:CD002843
  23. Katz BP, Caine VA, Jones RB. Evaluation of field follow-up in a sexually transmitted disease clinic for patients at risk for infection with Neisseria gonorrhoeae and Chlamydia trachomatis. Sex Transm Dis. 1992;19:99–104
  24. Trelle S, Shang A, Nartey L, et al. Improved effectiveness of partner notification for patients with sexually transmitted infections: Systematic review. Br Med J. 2007;334:354
  25. Young T, de Kock A, Jones H, et al. A comparison of two methods of partner notification for sexually transmitted infections in South Africa: Patient-delivered partner medication and patient-based partner referral. Int J STD AIDS. 2007;18:338–340
  26. Schillinger JA, Kissinger P, Calvet H, et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: A randomized, controlled trial. Sex Transm Dis. 2003;30:49–56
  27. Stekler J, Bachmann L, Brotman RM, et al. Concurrent sexually transmitted infections (STIs) in sex partners of patients with selected STIs: Implications for patient-delivered partner therapy. Clin Infect Dis. 2005;40:787–793
  28. Adimora AA. Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. Clin Infect Dis. 2002;35:S183–S186
  29. Rubinstein E. Comparative safety of the different macrolides. Int J Antimicrob Agents. 2001;18:S71–S76
  30. Centers for Disease Control and Prevention . Update to CDC's sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gonococcal infections. Morbid Mortal Wkly Rep. 2007;56:332–336
  31. Pichichero ME. A Review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics. 2005;115:1048–1057
  32. Hodge JG, Pulver A, Hogben M, et al. Expedited partner therapy for sexually transmitted diseases: Assessing the legal environment. Am J Public Health. 2008;98:238–243
  33. Golden MR, Anukam U, Williams DH, et al. The legal status of patient-delivered partner therapy for sexually transmitted infections in the United States: A national survey of state medical and pharmacy boards. Sex Transm Dis. 2005;32:112–114
  34. American Bar Association. Recommendation 116A. Available at http://www.abanet.org/leadership/2007/annual/docs/hundredsixteena.doc. Accessed November 25, 2008.
  35. American Academy of Pediatrics . Meningococcal infections. In:  Pickering LK,  Baker CJ,  Long SS,  McMillan JA editor. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, Illinois: American Academy of Pediatrics; 2006;p. 452–460
  36. Protecting adolescents: Ensuring access to care and reporting sexual activity and abuse. Position paper of the American Academy of Family Physicians, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the Society for Adolescent Medicine. J Adolesc Health. 2004;35:420–423
  37. Hogben M, Burstein GR. Expedited partner therapy for adolescents diagnosed with gonorrhea or chlamydia: A review and commentary. Adolesc Med Clin. 2006;17:687–695

 Policy statement approved by the Society for Adolescent Medicine Board of Directors, May 27, 2008, and supported by the American Academy of Pediatrics, March 4, 2009

PII: S1054-139X(09)00205-5

doi: 10.1016/j.jadohealth.2009.05.010

Journal of Adolescent Health
Volume 45, Issue 3 , Pages 303-309 , September 2009

Article Tools